[DEBUG-WINDOW 처리영역 보기]
즐겨찾기  |  뉴스레터  |  오늘의 정보 회원가입   로그인
BRIC홈 Bio마켓
연세대학교 의과학과
배너광고안내
이전
다음
스폰서배너광고 안내  배너1 배너2 배너3 배너4
연구중심병원 R&D 사업 동향
전체보기 할인행사 시약벤더 제품평가 기업정보
 
조회 86  인쇄하기 주소복사 트위터 공유 페이스북 공유 
[바이오클론] [USbiomax] Paraffin Bladder Tissue Array (38)
제품(기술)분류: Bio_Resource > 기타
전화: 02-2690-0058
메일: bioclone(at).bioclone.co.kr
팩스: 02-2690-0397

확대보기
상세정보 사용후기 회사정보 |  등록제품 |  시약벤더
  카탈로그 NO :
  제품 생산일 :
  원산지 :
  생산기업 :
  특징 및 규격  
 

US Biomax는 미국에 본사를 두고 있는 회사로, 다양한Paraffin Tissue Array, Paraffin Tissue Section등  을 제공하고 있습니다.

바이오 클론US Biomax의 한국 독점 대리점으로 합리적인 가격으로 제품을 제공하고 있습니다. 

www.bioclone.co.kr/usbiomax/

https://www.biomax.us/

upload_image

upload_image

Products List

Human Paraffin Embedded Tissue Array : Bladder

Name  Description  Cores  Cases 
BC12011c

Bladder cancer tissue array, including TNM, 63 cases/63 cores, replaced by BC12011d

63 63
BL1001

Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases/100 cores

100 25
BL1002b

Bladder cancer and normal tissue array, including pathology grade, TNM and clinical stage, 50 cases/ 100 cores, replacing BL1002a

100 50
BL1501

Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores, replaced by BL1501a

150 75
BL1501a

Multiple bladder carcinoma with bladder tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing BL1501

150 75
BL1921

Mid-advanced stage bladder cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases/192 cores

192 96
BL208

Bladder cancer with bladder tissue array (2016 WHO classification), including pathology grade, TNM and clinical stage, 69 cases/207 cores

207 69
BL2081b

High density bladder cancer with bladder tissue array, including pathology grade, TNM and clinical stage, 208 cases/208 cores, replacing BL2081a

208 208
BL2082a

Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 208 cases/ 208 cores, replacing BL2082

208 208
BL208a

Bladder cancer with bladder tissue array (2016 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 64 cases/192 cores, replacing BL208

192 64
BL241a

Bladder cancer tissue array with matched cancer adjacent tissue, including TNM and pathology grade, 10 cases/24 cores, replaced by BL241b

24 10
BL241b

Bladder urothelial carcinoma with matched cancer adjacent bladder tissue array, including TNM and clinical stage, 10 cases/24 cores, replacing BL241a

24 10
BL242

Bladder cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases/48 cores

48 24
BL243

Bladder cancer tissue array with normal tissues from autopsy, 12 cases/24 cores with stage and grade data

24 12
BL244a

Bladder cancer with matched cancer adjacent bladder tissue array, including TNM and clinical stage, 12 cases/24 cores, replacing BL244

24 12
BL481b

Bladder cancer tissue array with normal bladder tissue, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replaced by BL481c

48 48
BL481c

Bladder cancer with normal bladder tissue array, including TNM and clinical stage, 48 cases/48 cores, replacing BL481b

48 48
BL601

Bladder cancer (stage III-IV) tissue array, including TNM, clinical stage and pathology grade, 60 cases/60 cores

60 60
BL601a

Bladder cancer (stage III-IV) tissue array, including pathology grade, TNM and clinical stage, 60 cases/60 cores, replacing BL601

60 60
BL631

Bladder cancer tissue array with matched adjacent normal bladder tissue, including TNM and pathology grade, 24 cases/63 cores

63 24
BL721

Bladder cancer tissue array with normal tissues, 24 cases/72 cores

72 24
BL802b

Bladder cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing BL802a

80 80
BL803

Bladder cancer and normal tissue array with TNM and grade data, 40 cases/80 cores

80 40
BL804

Bladder disease spectrum (urocystic cancer progression) with bladder tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores

80 80
BL805

Mid-advanced stage bladder cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases/80 cores, replaced by BL805a

80 80
BL805b

Mid-advanced stage bladder cancer tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing BL805a

80 80
BL806b

Bladder cancer and bladder tissue array, including pathology grade, TNM and clinical stage, 60 cases/80 cores, replacing BL806a

80 60
BL807

Bladder cancer with bladder tissue array, including TNM and clinical stage, 80 cases/80 cores

80 80
BL921

Advanced stage multiple bladder cancer (most are stage III) tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), 92 cases/92 cores

92 92
BLC1501

Bladder cancer mid-density tissue array, 75 cases/150 cores

150 75
BLC241

Bladder cancer tissue array, 12 cases/24 cores

24 12
BLC661

Bladder cancer with adjacent normal bladder tissue array, including pathology grade, TNM and clinical stage, 33 cases/66 cores

66 33
BNC12011

Normal bladder tissue array, including TNM, clinical stage and pathology grade, 40 cases/ 80 cores

80 40
HBla-Uro105Sur-01

Bladder cancer tissue array, 59 cases. 46 cases have tumor and matched normal adjacent tissue (NAT)

105 59
HBlaU066Su01

Bladder carcinoma tissue microarray (56 cases) and normal adjacent tissue. With survival data. Replaces HBla-Uro105Sur-01

66 56
OD-CT-UrBla03-003

Human bladder carcinoma tissue array, cervix carcinoma, invasive edge tissue and normal adjacent tissue, 22 cases

58 22
T121b

Bladder cancer with bladder tissue test array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T121a

24 6
T124c

Bladder cancer with bladder tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing T124b

24 12

 

Homepage : www.bioclone.co.kr /> upload image


한국독점대리점 바이오클론

T) 02-2690-0058 F) 02-2690-0397

www.bioclone.co.kr

 

Homepage : www.bioclone.co.kr

사용후기
작성자*
내용*
만족도*
프리미엄 신제품신기술 프리미엄 등록이란?  
프리미엄 신제품신기술 등록 >
필코리아테크놀로지
필코리아테크놀로지 GFP보다 강한 fluorescence signal : NEB SNAP&CLIP tag protein lableing systems
필코리아테크놀로지
필코리아테크놀로지 간소화, 현대화, Phage Display Peptide Library Kit v2 소개합니다.
프리미엄 등록안내
위로가기
Bio마켓 홈  |  Bio마켓FAQ
 |  BRIC소개  |  이용안내  |  이용약관  |  개인정보처리방침  |  이메일무단수집거부
Copyright © BRIC. All rights reserved.  |  문의
트위터 트위터    페이스북 페이스북   유튜브 유튜브    RSS서비스 RSS
에펜도르프코리아 광고